Musculo-skeletal disorders, Planning

Applied filters

Guidance (42)
- Advanced therapy medicinal products (7)
- Safety in Breastfeeding (31)
- Stability in dosette boxes (14)
- Stability outside the fridge (19)
Medicine (68)
- Abatacept (1)
- Adalimumab (1)
- Amifampridine (1)
- Anakinra (1)
- Apremilast (1)
- Ataluren (1)
- Baricitinib (1)
- Belimumab (1)
- Brodalumab (1)
- Burosumab (1)
- Calcitonin (1)
- Canakinumab (1)
- Capsaicin (1)
- Celecoxib (1)
- Certolizumab pegol (1)
- Ciclosporin (1)
- Collagenase clostridium histolyticum (1)
- Denosumab (1)
- Dexamethasone (1)
- Dexketoprofen (1)
- Diazepam (1)
- Eculizumab (1)
- Etanercept (1)
- Etoricoxib (1)
- Fampridine (1)
- Febuxostat (1)
- Filgotinib (1)
- Golimumab (1)
- Ibandronic acid (1)
- Ibuprofen (1)
- Idebenone (1)
- Infliximab (1)
- Ixekizumab (1)
- Mexiletine (1)
- Nusinersen (1)
- Ofatumumab (1)
- Parathyroid hormone (1)
- Pridinol (1)
- Rasburicase (1)
- Risedronate sodium (1)
- Rituximab (1)
- Romosozumab (1)
- Secukinumab (1)
- Sodium hyaluronate (1)
- Strontium ranelate (1)
- Tadalafil (1)
- Teriparatide (1)
- Tiludronic acid (1)
- Tizanidine (1)
- Tocilizumab (1)
- Tofacitinib (1)
- Triamcinolone hexacetonide (1)
- Upadacitinib (1)
- Ustekinumab (1)
- Zoledronic acid (1)
Planning (101)
- Biosimilars (6)
- New Medicines (89)
  - CCG commissioned new medicines (51)
  - NHS England commissioned new medicines (49)
  - Pre-registration new medicines (UK/EU) (13)
- Patent expiries (43)
Specialty (101)
- Allergy and immunology (4)
- Anaesthesia and pain (7)
- Cancers (8)
- Cardiovascular system disorders (4)
- Diabetes (1)
- Ear, nose and throat disorders (1)
- Endocrine system disorders (5)
- Eyes and vision (6)
- Gastrointestinal disorders (7)
- Haematological disorders (2)
- Infection and infectious diseases (2)
- Mental health and illness (4)
- Musculo-skeletal disorders (101)
- Neurological disorders (9)
- Nutritional and metabolic disorders (1)
- Renal and urologic disorders (1)
- Respiratory disorders (1)
- Skin disorders (14)